blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2358738

EP2358738 - MODULATORS OF THE CX3CR1 RECEPTOR AND THERAPEUTIC USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.09.2015
Database last updated on 18.11.2024
Most recent event   Tooltip25.09.2015Application deemed to be withdrawnpublished on 28.10.2015  [2015/44]
Applicant(s)For all designated states
Université Pierre et Marie Curie (Paris 6)
4, Place Jussieu
75005 Paris / FR
[N/P]
Former [2011/34]For all designated states
UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS VI)
Tour Centrale 4, Place Jussieu
75005 Paris / FR
Inventor(s)01 / GOROCHOV, Guy
62 rue Domremy
F-75013 Paris / FR
02 / DORGHAM, Karim
6 allée Quincey
F-94200 Ivry Sur Seine / FR
03 / COMBADIERE, Christophe
18 rue du Réage
F-77700 Magny Le Hongre / FR
04 / DETERRE, Philippe
15 rue de Rungis
F-75013 Paris / FR
 [2011/34]
Representative(s)Domenego, Bertrand
Cabinet Lavoix
2, Place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
[N/P]
Former [2011/34]Domenego, Bertrand
Cabinet Lavoix 2, place d'Estienne d'Orves
75441 Paris Cedex 09 / FR
Application number, filing date09801438.416.12.2009
[2011/34]
WO2009EP67325
Priority number, dateWO2008IB5568317.12.2008         Original published format: PCT/IB2008/055683
[2011/34]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010079063
Date:15.07.2010
Language:EN
[2010/28]
Type: A2 Application without search report 
No.:EP2358738
Date:24.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 15.07.2010 takes the place of the publication of the European patent application.
[2011/34]
Search report(s)International search report - published on:EP24.10.2013
ClassificationIPC:C07K7/06, A61K38/02
[2011/34]
CPC:
C07K7/06 (EP); A61K38/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/34]
TitleGerman:MODULATOREN DES CX3CR1-REZEPTORS UND IHRE THERAPEUTISCHE VERWENDUNG[2011/34]
English:MODULATORS OF THE CX3CR1 RECEPTOR AND THERAPEUTIC USES THEREOF[2011/34]
French:MODULATEURS DU RÉCEPTEUR CX3CR1 ET LEURS UTILISATIONS THÉRAPEUTIQUES[2011/34]
Entry into regional phase07.06.2011National basic fee paid 
07.06.2011Designation fee(s) paid 
07.06.2011Examination fee paid 
Examination procedure07.06.2011Examination requested  [2011/34]
02.05.2014Amendment by applicant (claims and/or description)
13.01.2015Despatch of a communication from the examining division (Time limit: M04)
27.05.2015Application deemed to be withdrawn, date of legal effect  [2015/44]
19.06.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/44]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.01.2015
Fees paidRenewal fee
22.12.2011Renewal fee patent year 03
24.12.2012Renewal fee patent year 04
28.12.2013Renewal fee patent year 05
22.12.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0055207  (US GOV HEALTH & HUMAN SERV [US], et al) [A] 6,12-14 * claims 36,37; sequence 3 *;
 [A]WO0160406  (MILLENNIUM PHARM INC [US], et al) [A] 1-3,7-29 * abstract *;
 [A]WO02076990  (ASTRAZENECA AB [SE], et al) [A] 1-3,7-29 * abstract *;
 [A]EP1734367  (CELLZOME AG [DE]) [A] 1,2,12,14 * page 34, line 27 * * page 34, line 32 * * page 34, line 36 *;
 [A]WO2008003327  (INAGEN APS [DK], et al) [A] 1-3,7-29 * claims 14,16,28,40-44,47-50; sequences 2a,10,11 *;
 [E]WO2010070394  (UNIV PARIS CURIE [FR], et al) [E] 1-3,7-29 * the whole document *;
 [A]  - DELALEU N ET AL., "Inhibition of experimental Sjogren's syndrome through immunization with Hsp60 and its peptide amino acids 437-460", ARTHRITIS & RHEUMATISM, JOHN WILEY & SONS, INC, US, vol. 58, no. 8, doi:10.1002/ART.23656, ISSN 0004-3591, (200808), pages 2318 - 2328, (20080730), XP009122944 [A] 1,2,12,14 * page 2319, column r, paragraph 3 *

DOI:   http://dx.doi.org/10.1002/art.23656
 [A]  - ELICES M J ET AL., "Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (199401), vol. 93, no. 1, doi:10.1172/JCI116975, ISSN 0021-9738, pages 405 - 416, XP009052418 [A] 1,2,6,12,14 * page 406, column l, paragraph 5 *

DOI:   http://dx.doi.org/10.1172/JCI116975
 [AD]  - INOUE A ET AL., "Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice", ARTHRITIS & RHEUMATISM, JOHN WILEY & SONS, INC, US, (200505), vol. 52, no. 5, doi:10.1002/ART.21007, ISSN 0004-3591, pages 1522 - 1533, XP009122926 [AD] 1-3,7-29 * abstract *

DOI:   http://dx.doi.org/10.1002/art.21007
 [A]  - COMBADIERE C ET AL., "Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US, (19980911), vol. 273, no. 37, doi:10.1074/JBC.273.37.23799, ISSN 0021-9258, pages 23799 - 23804, XP002158116 [A] 1-3,7-29 * abstract *

DOI:   http://dx.doi.org/10.1074/jbc.273.37.23799
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.